Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CCNT2 antisense RNA 1 (CCNT2-AS1) is a long non-coding RNA gene found in humans. It is transcribed antisense to the CCNT2 gene and is classified within the lncRNA family. While CCNT2-AS1 does not encode a protein, it has been implicated in the regulation of cancer cell proliferation, migration, and invasion, especially in glioma and breast cancer. Higher expression levels of CCNT2-AS1 are associated with malignancy progression and poor prognosis in certain cancers, suggesting its potential utility as a prognostic biomarker and as a candidate for future therapeutic targeting, though it is not currently a direct drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CCNT2 antisense RNA 1 (CCNT2-AS1).